Figure. 1

The TIGIT expression level in patients with cervical cancer. A Analysis of the TIGIT expression levels in cervical cancer tissues and normal cervical tissues from the GSE29570, GSE52903, GSE67522 and TCGA-GTEx databases. B The TIGIT expression level in PBMCs from patients with cervical cancer, patients with HSILs and individuals with normal cervix. C–E Correlation analysis of TIGIT and PD-1, TIGIT and LAG3 expression, TIGIT and Tim3 expression in PBMCs from patients with cervical cancer. F The level of TIGIT⁺ cells in cervical cancer tissues and adjacent tissues. The data are the mean ± SEM of the experiments. *P < 0.05, **P < 0.01